Leading biostatisticians and scholars are featured in our weekly department seminar series which covers a wide range of topics, issues and methods relevant to the field of biostatistics. 

Upcoming

Check our Calendar for upcoming lectures.

Recent Session Recordings

• December 10, 2020. Ross L. Prentice Endowed Lecture. Presentation: Striving for Balance: How to View Statistical Methods as Tradeoffs. Speaker: Ken Rice, PhD is a professor of biostatistics at the University of Washington and the Ross L. Prentice Endowed Professor for 2020-21.  Watch video
• December 3, 2020. Presentation: Sparse Factor Decomposition Accounting for Correlated Errors Applied to Phenome-wide Analysis of Genetic Associations  Speaker: Jean Morrison, PhD, Assistant Professor of Biostatistics, University of Michigan School of Public Health. Watch video.
• November 12, 2020. Norman Breslow Endowed Lecture. Presentation: Descriptive Statistics Meets Machine Learning? Speaker: Jon Wellner, PhD is a professor of statistics and biostatistics at the University of Washington. Due to technical difficulties, posting of the video recording for this lecture is delayed; however, you can access the speaker's slides here.
• October 29, 2020. At Warp Speed: Statistics and COVID-19 Vaccine Development. Speaker: David Benkeser, PhD, Assistant Professor of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University. Watch Video
• October 15, 2020. Harmonizing Electronic Health Records from Heterogeneous Systems via Automated Translation of Medical Concepts. Speaker: Xu Shi, PhD, Assistant Professor of Biostatistics, University of Michigan School of Public Health. Watch Video
• October 1, 2020. Presentation: Seeking COVID-19 Vaccines having Worthwhile Efficacy, and the Role of Platform Trials. Speaker: Thomas R. Fleming, PhD, Professor of Biostatistics and Statistics, University of Washington. Watch video. This session was presented and recorded on October 1 as part of a joint seminar with the UW Department of Statistics. Related Article for Background: COVID-19 vaccine trials should seek worthwhile efficacy, Krause P, Fleming T, Longini I, Lancet, 396, 10253, 741-3.